Luis Miguel Guachalla

Luis Miguel Guachalla

Auto-generated profile, based on publicly available information

Luis Miguel Guachalla

Arsanis Biosciences, Vienna, Austria

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2012 in Cell
Verified
Journal Article
Open access
JWJianwei Wang
Jianwei Wang
QSQian Sun
Qian Sun
YMYohei Morita
Yohei Morita
HJHong Jiang
Hong Jiang
AGAlexander Groß
Alexander Groß
KRK. Lenhard Rudolph
K. Lenhard Rudolph
Checkpoints that limit stem cell self-renewal in response to DNA damage can contribute to cancer protection but may also promote tissue aging. Molecular components that control stem cell responses to DNA damage remain to be delineated. Using in vivo RNAi screens, we identified basic leucine zipper transcription factor, ATF-like (BATF) as a major component limiting self-renewal of hematopoietic stem cells (HSCs) in response to telomere dysfunction and γ-irradiation. DNA damage induces BATF in a G-CSF/STAT3-dependent manner resulting in lymphoid differentiation of HSCs. BATF deletion improves HSC self-renewal and function in response to γ-irradiation or telomere shortening but results in accumulation of DNA damage in HSCs. Analysis of bone marrow from patients with myelodysplastic syndrome supports the conclusion that DNA damage-dependent induction of BATF is conserved in human HSCs. Together, these results provide experimental evidence that a BATF-dependent differentiation checkpoint limits self-renewal of HSCs in response to DNA damage.

14 May 2018 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
TRTim Rollenske
Tim Rollenske
VSValeria Szijarto
Valeria Szijarto
JLJolanta Lukasiewicz
Jolanta Lukasiewicz
LGLuis M. Guachalla
Luis M. Guachalla
KSKatarina Stojkovic
Katarina Stojkovic
HWHedda Wardemann
Hedda Wardemann

14 March 2015 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
Tangliang LiTangliang Li
Tangliang Li
YSYue Shi
Yue Shi
PWPei Wang
Pei Wang
LGLuis Miguel Guachalla
Luis Miguel Guachalla
BSBaofa Sun
Baofa Sun
ZWZhaoqi Wang
Zhaoqi Wang
Nonsense‐mediated mRNA decay (NMD) is a post‐transcriptional mechanism that targets aberrant transcripts and regulates the cellular RNA reservoir. Genetic modulation in vertebrates suggests that NMD is critical for cellular and tissue homeostasis, although the underlying mechanism remains elusive. Here, we generate knockout mice lacking Smg6/Est1, a key nuclease in NMD and a telomerase cofactor. While the complete loss of Smg6 causes mouse lethality at the blastocyst stage, inducible deletion of Smg6 is compatible with embryonic stem cell (ESC) proliferation despite the absence of telomere maintenance and functional NMD. Differentiation of Smg6‐deficient ESCs is blocked due to sustained expression of pluripotency genes, normally repressed by NMD, and forced down‐regulation of one such target, c‐Myc, relieves the differentiation block. Smg6‐null embryonic fibroblasts are viable as well, but are refractory to cellular reprograming into induced pluripotent stem cells (iPSCs). Finally, depletion of all major NMD factors compromises ESC differentiation, thus identifying NMD as a licensing factor for the switch of cell identity in the process of stem cell differentiation and somatic cell reprograming. Synopsis New genetic data show that the NMD pathway is dispensable for growth of embryonic stem cells (ESCs) but essential for differentiation and reprogramming via repression of key pluripotency genes. The RNA endonuclease Smg6 functions in telomere maintenance and nonsense‐mediated decay (NMD) in mouse ESCs and MEFs. Loss of Smg6 does not compromise the viability of ESCs and MEFs. Smg6 regulates ESC differentiation and somatic cellular reprograming via its NMD function, not telomere maintenance. Smg6 modulates ESC differentiation by controlling mRNA stability of pluripotency genes, for example, c‐Myc. The NMD pathway acts as a general RNA surveillance mechanism safeguarding the cell identity switch.

1 February 2016 in International Journal of Medical Microbiology
Verified
Journal Article
Closed access
VSValéria Szijártó
Valéria Szijártó
LGLuis Miguel Guachalla
Luis Miguel Guachalla
KHKatharina Hartl
Katharina Hartl
CVCecília Varga
Cecília Varga
PBPallavi Banerjee
Pallavi Banerjee
GNGábor Nagy
Gábor Nagy

4 December 2011 in Nature Cell Biology
Verified
Journal Article
Closed access
PDF file
TSTobias Sperka
Tobias Sperka
ZSZhangfa Song
Zhangfa Song
YMYohei Morita
Yohei Morita
KNKodandaramireddy Nalapareddy
Kodandaramireddy Nalapareddy
LGLuis Miguel Guachalla
Luis Miguel Guachalla
KRK. Lenhard Rudolph
K. Lenhard Rudolph

14 February 2017 in Virulence
Verified
Journal Article
Open access
VSValéria Szijártó
Valéria Szijártó
LGLuis M. Guachalla
Luis M. Guachalla
KHKatharina Hartl
Katharina Hartl
CVCecília Varga
Cecília Varga
ABAdriana Badarau
Adriana Badarau
GNGábor Nagy
Gábor Nagy
Klebsiella pneumoniae ST258 is a globally distributed multi-drug resistant pathogen responsible for severe invasive infections. In this study, the different virulence potential of K. pneumoniae ST258 isolates in endotoxin susceptible versus resistant animal models was shown. Furthermore, ST258 clinical isolates were found highly sensitive to the bactericidal effect of naive animal and human serum. These observations imply that LPS, released from the rapidly lysed bacteria, may contribute to the high mortality associated with ST258 bacteremia cases. A humanized version (mAb A1102) of a previously described murine mAb specific for the conserved LPS O-antigen, was tested for endotoxin neutralization. A1102 was able to neutralize TLR-4 activation by ST258-derived LPS in vitro with an efficacy exceeding that of polymyxin B by 3 orders of magnitude. Passive immunization with A1102 afforded a significant level of protection in a galactosamine-sensitized mouse model of endotoxemia, induced by ST258-derived LPS, or upon challenge with live bacteria. Efficacy was retained using an aglycosylated IgG, as well as upon complement depletion, suggesting that Fc-independent endotoxin neutralization may be the main protective mechanism in this model, in spite of the complement-dependent bactericidal and opsonic activities additionally observed for A1102 in vitro. Furthermore, rabbits that are naturally highly susceptible to endotoxin, were also significantly protected by low doses of A1102 when challenged with an ST258 strain. Given this unique mode of action and the high protective efficacy of this mAb, passive immunization, as prophylactic or adjunct therapeutic approach for the treatment of infections caused by ST258 isolates should be considered.